View Cart  

Supreme Court Sides With Generic-Drug Makers in Ruling

The Supreme Court has unanimously ruled that generic-drug maker Caraco Pharmaceuticals can challenge Novo Nordisk’s “overbroad” patent listing for diabetes drug Prandin, reversing and remanding a lower court’s decision that critics called an existential threat to the generic industry.

To View This Article:


Buy This Article Now

Add this article to your cart for $25.00